Buscar
01/08/2025
Lipoprotein (a) and incident coronary heart disease in the community: Impact of traditional cardiovascular risk factors
Arnold, N, Gossling, A, Bay, B, Weimann, J, Blaum, C, Brunner, FJ, Ferrario, M, Brambilla, P, Cesana, G, Leoni, V, Palmieri, L, Donfrancesco, C, Padro, T, Andersson, J, Jousilahti, P, Ojeda, F, Zeller, T, Linneberg, A, Soderberg, S, Iacoviello, L, Gianfagna, F, Sans, S, Veronesi, G, Thorand, B, Peters, A, Tunstall-Pedoe, H, Kee, F, Salomaa, V, Schnabel, R, Kuulasmaa, K, Blankenberg, S, Waldeyer, C, Koenig, W. Lipoprotein (a) and incident coronary heart disease in the community: Impact of traditional cardiovascular risk factors. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/01/2025
Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease
López-Yerena, A, Villaplana, VD, Badimon, L, Vilahur, G, Padro, T. Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease. Nutrients. 2025; 17(1)DOI:10.3390/nu17010052. PMID:39796486. IF:5.000(Q1/2D).
01/12/2024
First time ACS in patients with on-target lipid levels: Inflammation at admission and re-event rate at follow-up
Muñoz-García, N, Cordero, A, Padro, T, Mendieta, G, Vilahur, G, Flores, E, Badimon, L. First time ACS in patients with on-target lipid levels: Inflammation at admission and re-event rate at follow-up. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(12)DOI:10.1111/eci.14305. PMID:39159006. IF:3.600(Q1/2D).
28/10/2024
Collagen VI and endotrophin: potential extracellular matrix targets to attenuate adverse cardiac remodeling post-infarction
Garcia-Arguinzonis, M, Vilahur, G, De Santisteban,, Badimon, L, Padro, T. Collagen VI and endotrophin: potential extracellular matrix targets to attenuate adverse cardiac remodeling post-infarction. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.3724. PMID:. IF:35.600(Q1/1D).
10/09/2024
What is the role of sex and gender in the future of precision cardiology?
Ministrini, S, Padró, T. What is the role of sex and gender in the future of precision cardiology?. EUROPEAN HEART JOURNAL. 2024; 45(40)DOI:10.1093/eurheartj/ehae504. PMID:39254039. IF:35.600(Q1/1D).
01/09/2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study
de Isla, LP, Vallejo-Vaz, AJ, Watts, GF, Muñiz-Grijalvo, O, Alonso, R, Diaz-Diaz, JL, Arroyo-Olivares, R, Aguado, R, Argueso, R, Mauri, M, Romero, MJ, Alvarez-Baños, P, Mañas, D, Cepeda, JM, Gonzalez-Bustos, P, Casañas, M, Michan, A, Muñoz-Torrero, JFS, Faedo, C, Barba, MA, Dieguez, M, de Andrés, R, Hernandez, AM, Gonzalez-Estrada, A, Padró, T, Fuentes, F, Badimon, L, Mata, P. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study. Lancet Diabetes & Endocrinology. 2024; 12(9)DOI:10.1016/S2213-8587(24)00192-X. PMID:39098315. IF:41.800(Q1/1D).